These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 22507465)

  • 1. Steroid-free living donor liver transplantation for HCV--a multicenter prospective cohort study in Japan.
    Marubashi S; Umeshita K; Asahara T; Fujiwara K; Haga H; Hashimoto T; Hatakeyama K; Ichida T; Kanematsu T; Kitajima M; Kiyosawa K; Makuuchi M; Miyagawa S; Satomi S; Soejima Y; Takada Y; Tanaka N; Teraoka S; Monden M
    Clin Transplant; 2012; 26(6):857-67. PubMed ID: 22507465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-free living donor liver transplantation in adults: impact on hepatitis C recurrence.
    Marubashi S; Dono K; Nagano H; Kim C; Asaoka T; Hama N; Kobayashi S; Takeda Y; Umeshita K; Monden M; Doki Y; Mori M
    Clin Transplant; 2009; 23(6):904-13. PubMed ID: 19573088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, multicenter trial comparing tacrolimus plus mycophenolate mofetil to tacrolimus plus steroids in hepatitis C virus-positive recipients of living donor liver transplantation.
    Takada Y; Kaido T; Asonuma K; Sakurai H; Kubo S; Kiuchi T; Inomata Y; Isaji S; Tsumura H; Teramukai S; Matsubara Y; Sakabayashi S; Uemoto S
    Liver Transpl; 2013 Aug; 19(8):896-906. PubMed ID: 23696054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
    Margarit C; Bilbao I; Castells L; Lopez I; Pou L; Allende E; Escartin A
    Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience.
    Sher L; Jennings L; Rudich S; Alexopoulos SP; Netto G; Teperman L; Kinkhabwala M; Brown RS; Pomfret E; Klintmalm G;
    Clin Transplant; 2012; 26(3):502-9. PubMed ID: 22151078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
    Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Charlton M; Seaberg E
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S107-14. PubMed ID: 10431024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation.
    Sreekumar R; Gonzalez-Koch A; Maor-Kendler Y; Batts K; Moreno-Luna L; Poterucha J; Burgart L; Wiesner R; Kremers W; Rosen C; Charlton MR
    Hepatology; 2000 Nov; 32(5):1125-30. PubMed ID: 11050065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers.
    Urbani L; Mazzoni A; Colombatto P; Bindi L; Biancofiore G; Tascini C; Menichetti F; Brunetto MR; Scatena F; Filipponi F
    Transplantation; 2008 Dec; 86(12):1666-71. PubMed ID: 19104402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
    Gutiérrez-Moreno M; Bernal-Bellido C; Suárez-Artacho G; Alamo-Martínez JM; Marín-Gómez LM; Serrano-Díaz-Canedo J; Padillo-Ruiz FJ; Gómez-Bravo MA
    Transplant Proc; 2012 Sep; 44(7):2100-2. PubMed ID: 22974923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft and viral outcomes in retransplantation for hepatitis C virus recurrence and HCV primary liver transplantation: a case-control study.
    Martí J; De la Serna S; Crespo G; Forns X; Ferrer J; Fondevila C; Navasa M; Fuster J; García-Valdecasas JC
    Clin Transplant; 2014 Jul; 28(7):821-8. PubMed ID: 24806099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
    Lladó L; Xiol X; Figueras J; Ramos E; Memba R; Serrano T; Torras J; Garcia-Gil A; Gonzalez-Pinto I; Castellote J; Baliellas C; Fabregat J; Rafecas A;
    J Hepatol; 2006 Apr; 44(4):710-6. PubMed ID: 16487622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
    Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
    Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial measurements of hepatitis C viral load by real-time polymerase chain reaction among recipients of living-donor renal transplants: a short-term follow-up study from a single center.
    Justa S; Minz RW; Minz M; Sharma A; Anand S; Das A; Chawla YK; Sakhuja VK
    Transplant Proc; 2010 Nov; 42(9):3568-73. PubMed ID: 21094817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.